Get in touch

Clinical

From neurotechnology to clinical recovery

CERVA is being developed as a non-invasive neuromodulation platform for neurorehabilitation, designed to complement conventional rehabilitation by pairing targeted stimulation with therapeutic exercises.

Our initial clinical development is focused on upper-limb motor recovery, where activity-dependent neuroplasticity plays a fundamental role in relearning movement and recovering function.

Illustrative scene of a therapist guiding a patient through an upper-limb reach-and-grasp exercise

Our first clinical focus

Upper-limb
neurorehabilitation

Motor recovery through targeted stimulation paired with therapeutic movement.

Illustrative rehabilitation scene

Upper-limb neurorehabilitation

Our first clinical focus

CERVA combines vagus nerve and motor cortex neuromodulation with rehabilitation exercises, with the objective of reinforcing the neural activity associated with specific movements.

01

Vagus nerve

Neuromodulation

02

Motor cortex

Targeted stimulation

03

Therapeutic exercises

Specific movements

The platform is being designed for integration into existing rehabilitation workflows and potentially with robotic, digital and software-based rehabilitation systems.

Potential applications

Exploring where neuroplasticity may matter

The underlying technology could provide a platform for investigating neuromodulation across several neurological and neuropsychiatric conditions in which neural plasticity and network modulation may be therapeutically relevant.

Stroke rehabilitation

Traumatic brain injury

Spinal cord injury

Other motor impairments

Chronic pain

Depression and anxiety

Post-traumatic stress disorder

Sleep disorders

Addiction

Each potential indication would require dedicated scientific validation, clinical investigation and the applicable regulatory authorization.

Beyond a single indication

One platform.
Multiple possibilities.

CERVA’s combination of electrical and mechanical stimulation, multiple neural targets, physiological monitoring and adaptive algorithms creates a technology platform that could potentially be configured for different therapeutic applications.

Our development strategy starts with motor neurorehabilitation and is designed to progressively explore additional applications supported by scientific and clinical evidence.

01

Initial focus

Motor neurorehabilitation

Upper-limb motor recovery

02

Explore

Additional applications

Potential neurological and neuropsychiatric indications

03

Advance with evidence

Scientific and clinical validation

With applicable regulatory authorization

Investigational technology

CERVA is an investigational technology under development. Clinical efficacy and safety for the applications described have not yet been established.